Gender differences in AIDS-associated Kaposi Sarcoma in Harare, Zimbabwe

Article Abstract:

A study report provides the first systematic description of the characteristics of AIDS-related Kaposi sarcoma (AIDS-KS) in African women and the first comparison of the viral and immunologic markers of HIV-1 and KS disease in women and men. The findings reveal that women are more likely to have symptoms of fever, diaphoresis, or weight loss suggests underlying differences in the biology and pathogenesis of KS disease and/or HIV-1 disease in women compared with men or gender differences in the incidence of other coinfections.

Zimbabwe, Care and treatment, Prevention, Risk factors, Demographic aspects, AIDS patients, Sex factors in disease, Disease sex factors, Human herpesvirus 8, Harare, Zimbabwe, Clinical report

---

Improving HIV surveillance in Victoria: The role of "detuned" enzyme immunoassay

Article Abstract:

The results of the detuned enzyme immunoassay (EIA) and the local surveillance method of classifying incident cases of HIV in Victoria in 1999 and 2000 are compared. It is recommended that a detuned assay or similar test become part of the routine strategy to identify incident infections in Victoria.

United States, HIV infection, HIV infections, Immunoenzyme technique, Immunoenzyme techniques

---

Similar abstracts:

• Abstracts: Are there differences in information given to private and public prenatal patients? Research agenda for preterm birth: Recommendations from the March of Dimes
• Abstracts: The scope of duty hour-associated residency structure modifications. Midtrimester amniotic fluid matrix metalloproteinase-8 (MM-8) levels above the 90th percentile are a maker for subsequent preterm premature rupture of membranes
• Abstracts: Nurses split over physician assistants. Releasing time to care: The way forward. Methods of meeting patients' cancer information needs
• Abstracts: Preventing cervical cancer in the developing world. Letting go of the rope -- aggressive treatment, hospice care, and open access
• Abstracts: Adopting orphan drugs - Two dozen years of treating rare diseases. The ongoing regulation of generic drugs

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.